MHRA advice on amphotericin B

The MHRA has reminded healthcare professionals that the use of lipid-based and non-lipid-based formulations of amphotericin B is not interchangeable.

They have issued the following advice:

  • For Fungizone, do not exceed a total daily dose of 1.5mg/kg.
  • To prevent inadvertent overdose, verify the product name and dose before administration, especially if the dose prescribed exceeds 1.5mg/kg.

View MHRA Drug Safety Update

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

New antibiotic guidance for diabetic foot infection

New antibiotic guidance for diabetic foot infection

NICE has updated its guidance on the prevention and...

Drug shortages - live tracker

Drug shortages - live tracker

Added: co-fluampicil.
Use our constantly updated...

Further drug shortages prompt advice to consider unlicensed alternatives

Further drug shortages prompt advice to consider unlicensed alternatives

Prescribers are being advised to prioritise supplies...

Vaping still safer than smoking, say health bosses after report of severe lung injury